Our approach to advancing your therapies beyond milestones to transforming lives.
Catalyst is a niche provider of clinical research
services through two established solutions.
Premier provider of multi-therapeutic
resourcing and CRO services helping to
drive healthcare innovations to patients in need.
A biotech-focused, niche oncology CRO
helping to bring next-generation therapies
to cancer patients in need.
Your success is based on finding real solutions and getting real results.
You deserve a partner who is fully invested in giving you their undivided attention.
Building a culture of customer through collaboration and doing what’s right.
Latest News
Catalyst Clinical Research Announces European-based Executive Leadership in Data Sciences and Project Management, Reinforcing Commitment to Region
The hires join several other senior leaders in the area in further strengthening the European footprint of the U.S.-headquartered CRO Wilmington, N.C., 23 May, 2023 – Catalyst Clinical Research, a market-leading provider of clinical research services, has announced...
Alert: Fraudulent recruiting
Job Scams Are Real. Protect your online job search from fraudulent recruitment practices.We have some terrific job opportunities at Catalyst Clinical Research, and our culture is rooted in transparency and values. You have the experience, and we have the position –...
Navigating Choppy Waters: Catalyst FLEX Delivers Rapid Study Completion for Anti-Nausea Compound
A U.S.-based, development-stage pharmaceutical company (the “Sponsor”) leveraged a relationship with an industry consultant to find a partner organization that could manage a new study within a particularly ambitious time frame. The Sponsor chose an organization whose...
“What makes a difference in this industry is how organizations stand behind their work. Catalyst has been hugely successful because of their integrity and commitment to their customers. No matter how big or small the project, they are your partner and that is why I continue to work with them.”
Mid-size Biopharma
